Biotech · Private company
Halia Therapeutics, Inc.
Track this companyFree. Adds Halia Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- HT-6184Phase 2 · PainClinicalTrials.gov · fetched Nov 12, 2026
- OfirnoflastPhase 2 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- HT-6184Phase 1 · Normal Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell TransfusionsPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07738510 · fetched Nov 12, 2026
- Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar ExtractionPHASE2 · COMPLETED · started Feb 12, 2024ClinicalTrials.gov NCT06241742 · fetched Nov 12, 2026
- Study to Evaluate HT-6184 in Healthy SubjectsPHASE1 · COMPLETED · started Jun 15, 2022ClinicalTrials.gov NCT05447546 · fetched Nov 12, 2026